Antibiotic therapy for Shigella dysentery

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Shigella dysentery is a global health concern, ranging from mild to fatal.
• Antibiotics are crucial for severe cases, but choices vary by region due to differing sensitivities and potential side effects.

Purpose of the Study:

• To systematically evaluate the efficacy and safety of various antibiotics for treating Shigella dysentery.

Main Methods:

• Conducted a comprehensive search of multiple databases and trial registries for randomized controlled trials (RCTs).
• Four authors independently assessed trial eligibility, quality, and extracted data.
• Analyzed dichotomous data using risk ratios (RR) with 95% confidence intervals (CI) and employed random-effects models for heterogeneity.

Main Results:

• Sixteen RCTs involving 1748 participants were included, spanning four decades.
• Limited evidence suggests antibiotics reduce diarrhea episodes.
• No single antibiotic class demonstrated superior efficacy, and heterogeneity impacted confidence in results. All studied antibiotics were safe, but evidence on relapse prevention was inadequate.

Conclusions:

• Antibiotics are effective in shortening the duration of Shigella dysentery.
• Regularly updated, region-specific antibiotic sensitivity data are essential for guiding empiric therapy.
• Further high-quality trials are needed to assess antibiotic roles in severe Shigella dysentery and high-risk populations.